Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII): fair value, margin of safety and Wheel Score

Is DMII undervalued?

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) closed at 10.19 on 16 Oct 2026. The GLS average fair value - the simple average of the 5 valuation models that produced a positive number - is 1,027.82, which puts the price 99% below it. 4 of the 5 models value the shares above the current price. A gap this wide is rare in our universe of ~7,400 US stocks and is exactly what the Value part of the Wheel Score rewards; it is also where the question "why is it this cheap?" matters most.

There is a wide gap between Graham Number (7.62) and GLS Growth (2,032.92). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.

The nightly engine files DMII under Speculative / Distressed - negative earnings or a Piotroski score of 3 or less - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.

Nine valuation models for DMII

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

Quality and financial health

Drugs Made In America Acquisition II Corp. Ordinary Shares scores only 0 of 9 on the Piotroski F-score, which fails the Sunday Scan's "6 or more" rule. A reading this low means several of the basic tests - positive earnings, positive operating cash flow, falling debt, no new share issuance - are not met. A GLS Moat score of 4.1/10 is a weak reading: the ten-year history the score grades (revenue, EPS, book value, margins, cash flow, share count, ROIC) has not been steady, so the Moat part of the Wheel Score contributes little.

Returns on capital are thin or negative - ROIC 0.9%, ROE 0.9%, ROA 0.8% - with debt at 0.00 times equity and negative free cash flow.

Drugs Made In America Acquisition II Corp. Ordinary Shares pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain.

Institutional ownership scores 10/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.

Wheel Score 39: No options

No options are listed on Drugs Made In America Acquisition II Corp. Ordinary Shares in our nightly snapshot. The Wheel Score is therefore capped at 39 (it reads 39) and the stock is left out of every options screen; the fair value and health figures above are still useful for a plain stock position.

Volume runs at 122k shares a day on a market cap of $649M, with a beta of 0.04 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 8 of 20.

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

No upcoming earnings date is recorded for DMII in the nightly calendar.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Financial - Conglomerates

The 12 companies below are the closest to Drugs Made In America Acquisition II Corp. Ordinary Shares by market cap within the Financial - Conglomerates industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

⚖ Compare DMII with 7 of them   All Financial Services stocks →